Henrik Vase
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Henrik Vase has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Jesper Nørgaard Bech
University Clinic in Nephrology and Hypertension, Gødstrup Hospital and Aarhus University, Herning, DENMARK
2 shared publications - Anna E Oczachowska-Kulik
Department of Medicine, Holstebro Hospital, Laegaardvej 12, Holstebro 7500, Denmark
1 shared publication - Anne Sp Kancir
University Clinic in Nephrology and Hypertension, Department of Medical Research and University of Aarhus, Holstebro Hospital, Holstebro, Denmark
1 shared publication - Annebirthe B Hansen
Department of Clinical Biochemistry, Holstebro Hospital, Holstebro, Denmark
1 shared publication - Bartlomiej Jonczy
Department of Medicine, Holstebro Hospital, Laegaardvej 12, Holstebro 7500, Denmark
1 shared publication - Carolina Cannillo Graffe
Dept. of Medical Research, Holstebro Hospital, Lægaardvej 12, Holstebro, Denmark
1 shared publication
Latest Publications
- Open Access
- 24 March 2014
- Published by Springer Nature in BMC Nephrology
- Vol. 15 (1) , 50
Cardiovascular effects of cholecalciferol treatment in dialysis patients – a randomized controlled trial
Patients on chronic dialysis are at increased risk of vitamin D deficiency. In observational studies plasma 25-hydroxyvitamin D (p-25(OH) D) levels are inversely correlated with plasma BNP and adverse cardiovascular outcomes. Whether a causal relation exists has yet to be established. The aim of this study was to test the hypothesis that cholecalciferol supplementation improves cardiac function and reduces blood pressure (BP) and pulse wave velocity (PWV) in patients on chronic dialysis.
- 24 March 2014
- Published by Springer Nature in BMC Nephrology
- Vol. 15 (1) , 50
Open AccessCardiovascular effects of cholecalciferol treatment in dialysis patients – a randomized controlled trial
Patients on chronic dialysis are at increased risk of vitamin D deficiency. In observational studies plasma 25-hydroxyvitamin D (p-25(OH) D) levels are inversely correlated with plasma BNP and adverse cardiovascular outcomes. Whether a causal relation exists has yet to be established. The aim of this study was to test the hypothesis that cholecalciferol supplementation improves cardiac function and reduces blood pressure (BP) and pulse wave velocity (PWV) in patients on chronic dialysis.
- Open Access
- 27 March 2012
- Published by Springer Nature in BMC Nephrology
- Vol. 13 (1) , 15
Abnormal increase in urinary aquaporin-2 excretion in response to hypertonic saline in essential hypertension
Dysregulation of the expression/shuttling of the aquaporin-2 water channel (AQP2) and the epithelial sodium channel (ENaC) in renal collecting duct principal cells has been found in animal models of hypertension. We tested whether a similar dysregulation exists in essential hypertension.
- 27 March 2012
- Published by Springer Nature in BMC Nephrology
- Vol. 13 (1) , 15
Open AccessAbnormal increase in urinary aquaporin-2 excretion in response to hypertonic saline in essential hypertension
Dysregulation of the expression/shuttling of the aquaporin-2 water channel (AQP2) and the epithelial sodium channel (ENaC) in renal collecting duct principal cells has been found in animal models of hypertension. We tested whether a similar dysregulation exists in essential hypertension.